Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways. (2017)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/leu.2017.116
PubMed Identifier: 28400619
Publication URI: http://europepmc.org/abstract/MED/28400619
Type: Journal Article/Review
Volume: 31
Parent Publication: Leukemia
Issue: 12
ISSN: 0887-6924